Cargando…
Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment
Although many diseases in which reactive oxygen species (ROS) and free radicals are involved in their pathogenesis are known, and antioxidants that effectively capture ROS have been identified and developed, there are only a few diseases for which antioxidants have been used for treatment. Here, we...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899923/ https://www.ncbi.nlm.nih.gov/pubmed/36777080 http://dx.doi.org/10.3164/jcbn.22-61 |
_version_ | 1784882739043893248 |
---|---|
author | Shichiri, Mototada Suzuki, Hiroshi Isegawa, Yuji Tamai, Hiroshi |
author_facet | Shichiri, Mototada Suzuki, Hiroshi Isegawa, Yuji Tamai, Hiroshi |
author_sort | Shichiri, Mototada |
collection | PubMed |
description | Although many diseases in which reactive oxygen species (ROS) and free radicals are involved in their pathogenesis are known, and antioxidants that effectively capture ROS have been identified and developed, there are only a few diseases for which antioxidants have been used for treatment. Here, we discuss on the following four concepts regarding the development of applications for disease treatment by regulating ROS, free radicals, and lipid oxidation with the findings of our research and previous reports. Concept 1) Utilization of antioxidants for disease treatment. In particular, the importance of the timing of starting antioxidant will be discussed. Concept 2) Therapeutic strategies using ROS and free radicals. Methods of inducing ferroptosis, which has been advocated as an iron-dependent cell death, are mentioned. Concept 3) Treatment with drugs that inhibit the synthesis of lipid mediators. In addition to the reduction of inflammatory lipid mediators by inhibiting cyclooxygenase and leukotriene synthesis, we will introduce the possibility of disease treatment with lipoxygenase inhibitors. Concept 4) Disease treatment by inducing the production of useful lipid mediators for disease control. We describe the treatment of inflammatory diseases utilizing pro-resolving mediators and propose potential compounds that activate lipoxygenase to produce these beneficial mediators. |
format | Online Article Text |
id | pubmed-9899923 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | the Society for Free Radical Research Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-98999232023-02-11 Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment Shichiri, Mototada Suzuki, Hiroshi Isegawa, Yuji Tamai, Hiroshi J Clin Biochem Nutr Review Although many diseases in which reactive oxygen species (ROS) and free radicals are involved in their pathogenesis are known, and antioxidants that effectively capture ROS have been identified and developed, there are only a few diseases for which antioxidants have been used for treatment. Here, we discuss on the following four concepts regarding the development of applications for disease treatment by regulating ROS, free radicals, and lipid oxidation with the findings of our research and previous reports. Concept 1) Utilization of antioxidants for disease treatment. In particular, the importance of the timing of starting antioxidant will be discussed. Concept 2) Therapeutic strategies using ROS and free radicals. Methods of inducing ferroptosis, which has been advocated as an iron-dependent cell death, are mentioned. Concept 3) Treatment with drugs that inhibit the synthesis of lipid mediators. In addition to the reduction of inflammatory lipid mediators by inhibiting cyclooxygenase and leukotriene synthesis, we will introduce the possibility of disease treatment with lipoxygenase inhibitors. Concept 4) Disease treatment by inducing the production of useful lipid mediators for disease control. We describe the treatment of inflammatory diseases utilizing pro-resolving mediators and propose potential compounds that activate lipoxygenase to produce these beneficial mediators. the Society for Free Radical Research Japan 2023-01 2022-10-18 /pmc/articles/PMC9899923/ /pubmed/36777080 http://dx.doi.org/10.3164/jcbn.22-61 Text en Copyright © 2023 JCBN https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Review Shichiri, Mototada Suzuki, Hiroshi Isegawa, Yuji Tamai, Hiroshi Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment |
title | Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment |
title_full | Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment |
title_fullStr | Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment |
title_full_unstemmed | Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment |
title_short | Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment |
title_sort | application of regulation of reactive oxygen species and lipid peroxidation to disease treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899923/ https://www.ncbi.nlm.nih.gov/pubmed/36777080 http://dx.doi.org/10.3164/jcbn.22-61 |
work_keys_str_mv | AT shichirimototada applicationofregulationofreactiveoxygenspeciesandlipidperoxidationtodiseasetreatment AT suzukihiroshi applicationofregulationofreactiveoxygenspeciesandlipidperoxidationtodiseasetreatment AT isegawayuji applicationofregulationofreactiveoxygenspeciesandlipidperoxidationtodiseasetreatment AT tamaihiroshi applicationofregulationofreactiveoxygenspeciesandlipidperoxidationtodiseasetreatment |